title: [Overweight and obesity are risk factors for development of cardiotoxicity from anthracyclines or sequential administration of anthracyclines and trastuzumab].
authors.affiliation: Universitätsklinik für Innere Medizin 5, Klinikum Nürnberg, Paracelsus Medizinische Privatuniversität, Prof.-Ernst-Nathan-Str. 1, Nürnberg, Deutschland. martin.wilhelm@klinikum-nuernberg.de.
authors.forename: Martin
authors.initials: M
authors.lastname: Wilhelm
mesh_terms: D000328:Adult; D000368:Aged; D018943:Anthracyclines / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000453:epidemiology*; D015984:Causality; D015897:Comorbidity; D004305:Dose-Response Relationship, Drug; D005260:Female; D005602:France / Q000453:epidemiology; D006331:Heart Diseases / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000453:epidemiology; D050177:Overweight / Q000453:epidemiology*; D012307:Risk Factors; D000068878:Trastuzumab / Q000008:administration & dosage*
chemical_list: D018943:Anthracyclines; D000970:Antineoplastic Agents; D000068878:Trastuzumab